Lumendi Company Market Research Report
Company Overview
Name: Lumendi, LLC
Mission: Lumendi is committed to creating technologies that enable physicians to perform at a higher level and minimize risk and recovery time for patients.
Founded: December 2014
Founders: No specific information on the founding members except for Peter Johann, who is listed as Founder, Chairman, & CEO.
Key People:
- Peter Johann, Founder, Chairman, & CEO
- Mike Parrilla, Chief Operating Officer
- James J. White, Vice President, Medical Affairs
- Eric Coolidge, Vice President, Sales & Marketing
- Robert Lulo, Senior Training Director
- Erwin van Wijk, Senior Director Business Development Europe
- Clinical Advisors include notable experts such as Dr. Sergey V. Kantsevoy, Emre Gorgun, MD, David L. Diehl, MD, and Mohamed O. Othman, MD.
Headquarters: Westport, Connecticut, USA
Number of Employees: No specific information available.
Revenue: No specific information available.
What the Company is Known For: Lumendi is primarily known for its innovations in medical devices designed to perform less invasive endoluminal procedures, particularly in the gastrointestinal tract.
Products
1. DiLumen® Endoluminal Interventional Platform (EIP):
- Description: A revolutionary platform enabling less invasive gastrointestinal procedures.
- Key Features:
- Two-balloon design improves control and tissue manipulation in colonoscopy procedures.
- Creates a stabilized therapeutic zone within the GI tract.
2. DiLumen EZ Glide:
- Description: Enhances complex endoscopic procedures with superior navigation, stability, and control.
- Key Features:
- Incorporates EZ Glide hydrophilic coating for better maneuverability.
- Balloon-enhanced navigation and visualization.
- Designed for procedures like EMR and ESD.
3. DiLumen EZ¹:
- Description: A single-use, disposable endotherapy sheath for complex endoscopic procedures.
- Key Features:
- Fits over standard and small-diameter endoscopes.
- Features a simplified one-balloon design for improved stability.
- Provides enhanced visualization and precise control.
4. DiLumen C¹ and DiLumen C²:
- Description: Devices offering greater control in challenging endosurgical procedures.
- Key Features:
- DiLumen C¹ offers 1 working channel; C² offers 2 (pending).
- Designed for complex polypectomies and colonic interventions.
Recent Developments
1. New Product Launches:
- DiLumen EZ¹ has been launched as a new variant aimed at tackling complex procedures.
- Lumendi has also been working on expanding the platform with DiLumen C1 and upcoming C2.
2. Technological Enhancements:
- The DiLumen EZ Glide now possesses an innovative hydrophilic coating enhancing endoscopic efficiency.
- Introduction of robotic-like features and additional working channels in newer variants like DiLumen C2.
3. Strategic Partnerships and Trials:
- Lumendi achieved successful customer evaluation phases for DiLumen EZ¹.
- The company has forged relationships with clinical advisors and medical leaders to advance its technological outreach.
- Conducted successful clinical trials such as the first-in-human trials for the DiLumen EIP with positive results reported.
4. Market Expansion Efforts:
- Ongoing efforts to pursue market expansions in Europe and Asia.
- Plans to increase product adoption among GI practitioners and transition to less invasive surgical options.
Conclusion
Lumendi has positioned itself as a leader in innovative endosurgery solutions with a strong product lineup focused on improving clinical outcomes for complex gastrointestinal procedures. Its strategic focus on expanding its product offerings and geographical footprint is likely to further cement its status in the medical device landscape.